Action Ivz Sp Eqw A

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

4 600,00

Prix Achat

4 605,00

Prix Vente

4 609,50

Volume échangé

33 896

4 602,75 Fourchette du Jour 4 707,75

0,00 Plage de 52 semaines 0,00

Clôture Veille

4 749,50

Ouverture

4 696,50

Dernière Transaction

428

4601.79

(O)

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

1 567 911p

VWAP

4 625,6516

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP 30 April 2021 NAV/per Shares in Net Asset share Funds Date ISIN code Issue Currency Value Base Invesco S&P...

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP 28 April 2021 NAV/per Shares in Net Asset share Funds Date ISIN code Issue Currency Value Base Invesco S&P...

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP 28 April 2021 NAV/per Shares in Net Asset share Funds Date ISIN code Issue Currency Value Base Invesco S&P...

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP 19 April 2021 NAV/per Shares in Net Asset share Funds Date ISIN code Issue Currency Value Base Invesco S&P...

Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes

Company Signs Long-term Supply Agreement for Pharmaceutical D-tagatose BETHESDA, Md., Jan. 12 /PRNewswire-FirstCall/ -- Spherix Inc. (Nasdaq...

Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco

BETHESDA, Md., Jan. 11 /PRNewswire-FirstCall/ -- Spherix Inc. (NASDAQ: SPEX), an innovator in biotechnology for diabetes therapy, and a provider...

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a...

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a...

Spherix Announces Results of Annual Shareholders Meeting

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a...

Spherix Incorporated Appoints Dr. Ram Nimmagudda As Director of New Business Development

BETHESDA, Md., Sept 10 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Ivz Sp Eqw A (SPEX)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

SPEX Dernières nouvelles

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes

Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

Spherix Announces Results of Annual Shareholders Meeting

Spherix Incorporated Appoints Dr. Ram Nimmagudda As Director of New Business Development

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Ivz Sp Eqw A (SPEX) Cours

Ivz Sp Eqw A (SPEX)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

SPEX Dernières nouvelles

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes

Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

Spherix Announces Results of Annual Shareholders Meeting

Spherix Incorporated Appoints Dr. Ram Nimmagudda As Director of New Business Development

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP